Page last updated: 2024-10-25

clemizole and Long QT Syndrome

clemizole has been researched along with Long QT Syndrome in 1 studies

clemizole: was heading 1966-94 (see under BENZIMIDAZOLES 1966-90); use BENZIMIDAZOLES to search CLEMIZOLE 1966-94; a histamine H1- blocker used to treat allergies
clemizole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a pyrrolidin-1-ylmethyl and a 4-chlorobenzyl groups at positions 2 and 1 respectively.

Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jie, LJ1
Wu, WY1
Li, G1
Xiao, GS1
Zhang, S1
Li, GR1
Wang, Y1

Other Studies

1 other study available for clemizole and Long QT Syndrome

ArticleYear
Clemizole hydrochloride blocks cardiac potassium currents stably expressed in HEK 293 cells.
    British journal of pharmacology, 2017, Volume: 174, Issue:3

    Topics: Action Potentials; Animals; Benzimidazoles; Dose-Response Relationship, Drug; Electrocardiography; E

2017